- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 1134-1148 of
1,230 results
2345 Exhibit: Deposition Transcript of Szilard Kiss, MD, Vol 2 May 13, 2022 Redact...
Document
IPR2021-00816, No. 2345 Exhibit - Deposition Transcript of Szilard Kiss, MD, Vol 2 May 13, 2022 Redacted Version (P.T.A.B. May. 26, 2022)
|
|
Cite Document
1227 Exhibit: REG NDNY 00000004 Gilead Sciences Inc Form 10 K 16
Document
IPR2021-00816, No. 1227 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 16 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1234 Exhibit: ���Highlights of Prescribing Information,��� Lucentis, FDA, revised Feb...
Document
IPR2021-00816, No. 1234 Exhibit - ���Highlights of Prescribing Information,��� Lucentis, FDA, revised February 2015 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1191 Exhibit: Highlights of Prescribing Information, Macugen, revised July 2011
Document
IPR2021-00816, No. 1191 Exhibit - Highlights of Prescribing Information, Macugen, revised July 2011 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1240 Exhibit: ���Highlights of Prescribing Information,��� Lucentis, FDA, revised Apri...
Document
IPR2021-00816, No. 1240 Exhibit - ���Highlights of Prescribing Information,��� Lucentis, FDA, revised April 2017 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1238 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised March ...
Document
IPR2021-00816, No. 1238 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised March 2015 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1186 Exhibit: Highlights of Prescribing Information, Avastin, FDA, revised Decembe...
Document
IPR2021-00816, No. 1186 Exhibit - Highlights of Prescribing Information, Avastin, FDA, revised December 2020 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1179 Exhibit: Bayer HealthCare AG And Regeneron Pharmaceuticals, Inc To Collab...
Document
IPR2021-00816, No. 1179 Exhibit - Bayer HealthCare AG And Regeneron Pharmaceuticals, Inc To Collaborate On VEGF Trap For The Treatment Of Eye Diseases Regeneron Retains US Comm...
|
|
Cite Document
1106 Exhibit: Reply Declaration of Dr Szilard Kiss
Document
IPR2021-00816, No. 1106-2 Exhibit - Reply Declaration of Dr Szilard Kiss (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1187 Exhibit: Callan Navitsky, The Regulation of Compounding Pharmacies, Retina...
Document
IPR2021-00816, No. 1187 Exhibit - Callan Navitsky, The Regulation of Compounding Pharmacies, Retina Today, NovemberDecember 2012 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1199 Exhibit: Excerpt of Wooldridge, Jeffrey M, Econometric Analysis of Cross Sec...
Document
IPR2021-00816, No. 1199 Exhibit - Excerpt of Wooldridge, Jeffrey M, Econometric Analysis of Cross Section and Panel Data, MIT Press (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1241 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised May 20...
Document
IPR2021-00816, No. 1241 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised May 2019 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1177 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised March ...
Document
IPR2021-00816, No. 1177 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised March 2021 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1239 Exhibit: ���Highlights of Prescribing Information,��� Lucentis, FDA, revised Feb...
Document
IPR2021-00816, No. 1239 Exhibit - ���Highlights of Prescribing Information,��� Lucentis, FDA, revised February 2013 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1178 Exhibit: Novartis Ophthalmics and Genentech announce development and co...
Document
IPR2021-00816, No. 1178 Exhibit - Novartis Ophthalmics and Genentech announce development and commercialization agreement for age related macular degeneration treatment, LucentisTM...
|
|
Cite Document
